Multivariate analysis demonstrated that VM+, Notch4+, DLL4+, and/or KAI1/CD82+ specimens, and tumor size, LNM, distant metastasis (DM), and TNM stage, were independent prognostic factors for NSCLC (Table 4). This evidence concerns the gene CD82 and neoplasm.